Xiao-Hou Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xiao-Hou Wu has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Chunli Luo
Department of Laboratory Diagnosis, Chongqing Medical University, Chongqing, China (mainland)
9 shared publications Chunli Luo
Key Laboratory of Diagnostics Medicine designated by the Ministry of Education, Chongqing Medical University, Chongqing 400016, China
5 shared publicationsJia-Mo Zhang
5 shared publicationsYao Zhang
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
5 shared publicationsGang Chen
Chongqing Medical University
4 shared publicationsYao Zhang
4 shared publications
Latest Publications
- Open Access
- 18 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37783-37795
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
- 18 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37783-37795
Open AccessNegative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
- 21 January 2015
- Published by Springer Nature in Medical Oncology
- Vol. 32 (2) , 35-453
Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3
Myeloid-derived suppressor cells (MDSCs), one of the main cell populations, are responsible for regulating the immune response, which accumulates in tumor-bearing mice and humans contributing to cancer development. Exosomes produced by tumor cells have been involved in tumor-associated immune suppression. However, the role of exosomes is unclear in the activation of MDSCs. Here, we have purified tumor-derived exosomes from the supernatants of Renca cell cultures. Transmission electron microscopy was used to confirm their morphology, and Western blot analysis showed that Hsp70 was rich in these isolated exosomes compared with the whole-cell lysates of Renca cells. Then, we demonstrated that there was a more powerful activity of exosomal Hsp70-mediated induction of proinflammation cytokines, tumor growth factors of MDSCs and tumor progression than exosomes pre-incubated with anti-Hsp70 antibody. Furthermore, we show that an interactive exosomal HSP70 and MDSCs determine the suppressive activity of the MDSCs via phosphorylation of Stat3 (p-Stat3). Finally, we show that exosomal Hsp70 triggers p-Stat3 in MDSCs in a TLR2-MyD88-dependent manner. Meanwhile, we also find that there is a more significant increase in the percentage of CD11b+Gr-1+ cells in the mice, which are treated with exosomal Hsp70 than that exosomes pre-incubated with anti-Hsp70 antibody. Hence, we believe that the signaling pathway activation by exosomal Hsp70 within MDSCs may be a significant target in future treatment of renal cell carcinoma.
- 21 January 2015
- Published by Springer Nature in Medical Oncology
- Vol. 32 (2) , 35-453
Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3
Myeloid-derived suppressor cells (MDSCs), one of the main cell populations, are responsible for regulating the immune response, which accumulates in tumor-bearing mice and humans contributing to cancer development. Exosomes produced by tumor cells have been involved in tumor-associated immune suppression. However, the role of exosomes is unclear in the activation of MDSCs. Here, we have purified tumor-derived exosomes from the supernatants of Renca cell cultures. Transmission electron microscopy was used to confirm their morphology, and Western blot analysis showed that Hsp70 was rich in these isolated exosomes compared with the whole-cell lysates of Renca cells. Then, we demonstrated that there was a more powerful activity of exosomal Hsp70-mediated induction of proinflammation cytokines, tumor growth factors of MDSCs and tumor progression than exosomes pre-incubated with anti-Hsp70 antibody. Furthermore, we show that an interactive exosomal HSP70 and MDSCs determine the suppressive activity of the MDSCs via phosphorylation of Stat3 (p-Stat3). Finally, we show that exosomal Hsp70 triggers p-Stat3 in MDSCs in a TLR2-MyD88-dependent manner. Meanwhile, we also find that there is a more significant increase in the percentage of CD11b+Gr-1+ cells in the mice, which are treated with exosomal Hsp70 than that exosomes pre-incubated with anti-Hsp70 antibody. Hence, we believe that the signaling pathway activation by exosomal Hsp70 within MDSCs may be a significant target in future treatment of renal cell carcinoma.
- Open Access
- 11 March 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 7 (5) , 1576-1580
786-0 Renal cancer cell line-derived exosomes promote 786-0 cell migration and invasion in vitro
Emerging evidence indicates that cancer‑derived exosomes contribute to angiogenesis, tumor immunology and invasion. However, whether cancer cell‑derived exosomes regulate the migration and invasion of the cancer cell itself, and the underlying mechanisms are not well understood. In the present study, exosomes derived from the 786‑0 human renal cancer cell line were isolated, purified and 100 µg̸ml were co‑cultured with 786‑0 cells for 24 h. The 786‑0 cells were harvested for a cell invasion and migration assay. The expression of chemokine receptor type 4 (CXCR4) and matrix metalloproteinase‑9 (MMP‑9) in the 786‑0 cells was examined by western blot analysis and revealed that the migration and invasion capabilities of the 786‑0 cells were increased, however, the cell adhesion abilities were decreased as a result of the 24‑h treatment with 786‑0‑derived exosomes. Furthermore, the expression levels of CXCR4 and MMP‑9 in the 786‑0 cells were increased. In conclusion, the 786‑0 renal cancer cell line‑derived exosomes increased migration and invasion, however, they decreased the adhesion ability of the 786‑0 cells. The exosomes may have increased the CXCR4 and MMP‑9 expression levels in the 786‑0 cells. These findings indicated that renal tumor‑derived exosomes may contribute to renal cancer development and progression.
- 11 March 2014
- Published by Spandidos Publications in Oncology Letters
- Vol. 7 (5) , 1576-1580
Open Access786-0 Renal cancer cell line-derived exosomes promote 786-0 cell migration and invasion in vitro
Emerging evidence indicates that cancer‑derived exosomes contribute to angiogenesis, tumor immunology and invasion. However, whether cancer cell‑derived exosomes regulate the migration and invasion of the cancer cell itself, and the underlying mechanisms are not well understood. In the present study, exosomes derived from the 786‑0 human renal cancer cell line were isolated, purified and 100 µg̸ml were co‑cultured with 786‑0 cells for 24 h. The 786‑0 cells were harvested for a cell invasion and migration assay. The expression of chemokine receptor type 4 (CXCR4) and matrix metalloproteinase‑9 (MMP‑9) in the 786‑0 cells was examined by western blot analysis and revealed that the migration and invasion capabilities of the 786‑0 cells were increased, however, the cell adhesion abilities were decreased as a result of the 24‑h treatment with 786‑0‑derived exosomes. Furthermore, the expression levels of CXCR4 and MMP‑9 in the 786‑0 cells were increased. In conclusion, the 786‑0 renal cancer cell line‑derived exosomes increased migration and invasion, however, they decreased the adhesion ability of the 786‑0 cells. The exosomes may have increased the CXCR4 and MMP‑9 expression levels in the 786‑0 cells. These findings indicated that renal tumor‑derived exosomes may contribute to renal cancer development and progression.
- 8 May 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 8 (1) , 272-276
The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion molecule
The aims of the current study were to determine whether 786‑0 renal cancer cell‑derived exosomes promote human umbilical vein endothelial cells (HUVECs) to form tubular structures and to uncover the underlying mechanisms associated with this process. Exosomes were extracted and purified using ultrafiltration and sucrose gradient centrifugation and characterized by transmission electron microscopy. Tubular structure formation was observed using the matrigel tubular assay. In addition, an adenovirus vector was used to transfect the hepatocyte cell adhesion molecule (hepaCAM) gene into renal cancer 786‑0 cells. The expression of hepaCAM and vascular endothelial growth factor (VEGF) mRNA and protein was determined by reverse transcription‑polymerase chain reaction and western blot analysis, respectively. Tumor cell‑derived exosomes were observed to significantly increase tubular formation in HUVECs. Following transfection with the hepaCAM gene, VEGF expression in 786‑0 cells was markedly decreased. In HUVECs, exosome treatment increased VEGF mRNA and protein expression, while hepaCAM expression was only decreased at the protein level. In the present study, renal cancer 786‑0 cell‑derived exosomes significantly promoted angiogenesis via upregulation of VEGF expression in HUVECs, which may be induced by the downregulation of hepaCAM.
- 8 May 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 8 (1) , 272-276
The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion molecule
The aims of the current study were to determine whether 786‑0 renal cancer cell‑derived exosomes promote human umbilical vein endothelial cells (HUVECs) to form tubular structures and to uncover the underlying mechanisms associated with this process. Exosomes were extracted and purified using ultrafiltration and sucrose gradient centrifugation and characterized by transmission electron microscopy. Tubular structure formation was observed using the matrigel tubular assay. In addition, an adenovirus vector was used to transfect the hepatocyte cell adhesion molecule (hepaCAM) gene into renal cancer 786‑0 cells. The expression of hepaCAM and vascular endothelial growth factor (VEGF) mRNA and protein was determined by reverse transcription‑polymerase chain reaction and western blot analysis, respectively. Tumor cell‑derived exosomes were observed to significantly increase tubular formation in HUVECs. Following transfection with the hepaCAM gene, VEGF expression in 786‑0 cells was markedly decreased. In HUVECs, exosome treatment increased VEGF mRNA and protein expression, while hepaCAM expression was only decreased at the protein level. In the present study, renal cancer 786‑0 cell‑derived exosomes significantly promoted angiogenesis via upregulation of VEGF expression in HUVECs, which may be induced by the downregulation of hepaCAM.
- 1 October 2012
- Vol. 32 (10) , 1498-502
[Effects of renal carcinoma cell line ACHN-derived exosomes on ACHN cell proliferation and apoptosis].
To investigate the effects of exosomes derived from renal cancer cell line ACHN on the proliferation and apoptosis of ACHN cells and explore the mechanism. Exosomes derived from ACHN cells were separated and purified by ultrafiltration and sucrose gradient centrifugation. The effects of the exosomes on the proliferation and apoptosis of ACHN cells were analyzed with CCK-8 assay and flow cytometry, respectively. The changes of mRNA and protein expressions of cyclin D1, caspase-3 were examined using RT-PCR and Western blotting, and the changes in the protein expression of p-Akt and p-ERK1/2 were detected with Western blotting. Exosomes were successfully purified by ultrafiltration and sucrose gradient centrifugation. Compared with the control cells, ACHN cells treated with the exosomes showed enhanced proliferative activity with suppressed cell apoptosis. Exosomes treatment upregulated cyclinD1 mRNA and protein expression, down-regulated caspase-3 protein expression without affecting caspase-3 mRNA expression, and upregulated the expression of p-Akt and p-ERK1/2. Exosomes can promote the growth and proliferation and inhibit the apoptosis of renal cancer cell line ACHN. Removal of the exosomes from the microenvironment of renal cancer or inhibition of its function can be new strategies for treatment of renal cancer.
- 1 October 2012
- Vol. 32 (10) , 1498-502
[Effects of renal carcinoma cell line ACHN-derived exosomes on ACHN cell proliferation and apoptosis].
To investigate the effects of exosomes derived from renal cancer cell line ACHN on the proliferation and apoptosis of ACHN cells and explore the mechanism. Exosomes derived from ACHN cells were separated and purified by ultrafiltration and sucrose gradient centrifugation. The effects of the exosomes on the proliferation and apoptosis of ACHN cells were analyzed with CCK-8 assay and flow cytometry, respectively. The changes of mRNA and protein expressions of cyclin D1, caspase-3 were examined using RT-PCR and Western blotting, and the changes in the protein expression of p-Akt and p-ERK1/2 were detected with Western blotting. Exosomes were successfully purified by ultrafiltration and sucrose gradient centrifugation. Compared with the control cells, ACHN cells treated with the exosomes showed enhanced proliferative activity with suppressed cell apoptosis. Exosomes treatment upregulated cyclinD1 mRNA and protein expression, down-regulated caspase-3 protein expression without affecting caspase-3 mRNA expression, and upregulated the expression of p-Akt and p-ERK1/2. Exosomes can promote the growth and proliferation and inhibit the apoptosis of renal cancer cell line ACHN. Removal of the exosomes from the microenvironment of renal cancer or inhibition of its function can be new strategies for treatment of renal cancer.
- Open Access
- 20 August 2012
- Published by Medknow in Asian Journal of Andrology
- Vol. 14 (5) , 788-792
Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 20 August 2012
- Published by Medknow in Asian Journal of Andrology
- Vol. 14 (5) , 788-792
Open AccessUpregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 20 August 2012
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 188 (4) , 1346-1353
Exploration of the Correlations Between Interferon-γ in Patient Serum and HEPACAM in Bladder Transitional Cell Carcinoma, and the Interferon-γ Mechanism Inhibiting BIU-87 Proliferation
Interferon-γ inhibits cancer cell proliferation and induces re-expression of different tumor suppressor genes. As a candidate, HEPACAM is almost lost in bladder transitional cell carcinoma. To our knowledge whether interferon-γ inhibits BIU-87 proliferation and re-expresses HEPACAM mRNA is still unknown. Thus, we probed the mechanism and examined the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma. Using enzyme-linked immunosorbent assay we measured serum interferon-γ in 27 men and 6 women, and 15 volunteers. Disease was Ta–T1 in 12 patients, T2–T4 in 21, low grade in 25, high grade in 8, primary in 13 and recurrent in 20. A total of 33 cancer and 26 adjacent tissues were examined by immunohistochemistry to detect HEPACAM protein and ensure the position. Under interferon-γ stimulation we detected BIU-87 proliferation by MTT assay. Cell cycles were examined by flow cytometry. HEPACAM mRNA expression was determined by reverse transcription-polymerase chain reaction. Western blot was used to detect p21WAF1. Interferon-γ was remarkably low in patients with bladder transitional cell carcinoma vs volunteers (p HEPACAM mRNA (p 0/G1 and p21WAF1 was concurrently increased in response to interferon-γ (p WAF1 up-regulation to arrest cells at the G0/G1 phase.
- 20 August 2012
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 188 (4) , 1346-1353
Exploration of the Correlations Between Interferon-γ in Patient Serum and HEPACAM in Bladder Transitional Cell Carcinoma, and the Interferon-γ Mechanism Inhibiting BIU-87 Proliferation
Interferon-γ inhibits cancer cell proliferation and induces re-expression of different tumor suppressor genes. As a candidate, HEPACAM is almost lost in bladder transitional cell carcinoma. To our knowledge whether interferon-γ inhibits BIU-87 proliferation and re-expresses HEPACAM mRNA is still unknown. Thus, we probed the mechanism and examined the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma. Using enzyme-linked immunosorbent assay we measured serum interferon-γ in 27 men and 6 women, and 15 volunteers. Disease was Ta–T1 in 12 patients, T2–T4 in 21, low grade in 25, high grade in 8, primary in 13 and recurrent in 20. A total of 33 cancer and 26 adjacent tissues were examined by immunohistochemistry to detect HEPACAM protein and ensure the position. Under interferon-γ stimulation we detected BIU-87 proliferation by MTT assay. Cell cycles were examined by flow cytometry. HEPACAM mRNA expression was determined by reverse transcription-polymerase chain reaction. Western blot was used to detect p21WAF1. Interferon-γ was remarkably low in patients with bladder transitional cell carcinoma vs volunteers (p HEPACAM mRNA (p 0/G1 and p21WAF1 was concurrently increased in response to interferon-γ (p WAF1 up-regulation to arrest cells at the G0/G1 phase.
- Open Access
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 45 (8) , 771-776
In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
Intravesical chemotherapy is an important part of the treatment for superficial bladder cancer. However, the response to it is limited and its side effects are extensive. Functional single-walled carbon nanotubes (SWNT) have shown promise for tumor-targeted accumulation and low toxicity. In the present study, we performed in vivo and in vitro investigations to determine whether SWNT-based drug delivery could induce high tumor depression in rat bladder cancer and could decrease the side effects of pirarubicin (tetrahydropyranyl-adriamycin, THP). We modified SWNT with phospholipid-branched polyethylene glycol and constructed an SWNT-THP conjugate via a cleavable ester bond. The cytotoxicity of SWNT-THP against the human bladder cancer cell line BIU-87 was evaluated in vitro. Rat bladder cancer in situ models constructed by N-methyl-N-nitrosourea intravesical installation (1 g/L, 2 mg/rat once every 2 weeks for 8 weeks) were used for in vivo evaluation of the cytotoxicity of SWNT and SWNT-THP. Specific side effects in the THP group including urinary frequency (N = 12), macroscopic hematuria (N = 1), and vomiting (N = 7) were identified; however, no side effects were observed with SWNT-THP treatment. Flow cytometry was used to assess the cytotoxicity in vitro and in vivo. Results showed that SWNT alone did not yield significant tumor depression compared to saline (1.74 ± 0.56 and 1.23 ± 0.42%) in vitro. SWNT-THP exhibited higher tumor depression than THP-saline in vitro (74.35 ± 2.56 and 51.24 ± 1.45%) and in vivo (52.46 ± 2.41 and 96.85 ± 0.85%). The present findings indicate that SWNT delivery of THP for the treatment of bladder cancer leads to minimal side effects without loss of therapeutic efficacy. Therefore, this nanotechnology may play a crucial role in the improvement of intravesical treatment of bladder cancer.
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 45 (8) , 771-776
Open AccessIn vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
Intravesical chemotherapy is an important part of the treatment for superficial bladder cancer. However, the response to it is limited and its side effects are extensive. Functional single-walled carbon nanotubes (SWNT) have shown promise for tumor-targeted accumulation and low toxicity. In the present study, we performed in vivo and in vitro investigations to determine whether SWNT-based drug delivery could induce high tumor depression in rat bladder cancer and could decrease the side effects of pirarubicin (tetrahydropyranyl-adriamycin, THP). We modified SWNT with phospholipid-branched polyethylene glycol and constructed an SWNT-THP conjugate via a cleavable ester bond. The cytotoxicity of SWNT-THP against the human bladder cancer cell line BIU-87 was evaluated in vitro. Rat bladder cancer in situ models constructed by N-methyl-N-nitrosourea intravesical installation (1 g/L, 2 mg/rat once every 2 weeks for 8 weeks) were used for in vivo evaluation of the cytotoxicity of SWNT and SWNT-THP. Specific side effects in the THP group including urinary frequency (N = 12), macroscopic hematuria (N = 1), and vomiting (N = 7) were identified; however, no side effects were observed with SWNT-THP treatment. Flow cytometry was used to assess the cytotoxicity in vitro and in vivo. Results showed that SWNT alone did not yield significant tumor depression compared to saline (1.74 ± 0.56 and 1.23 ± 0.42%) in vitro. SWNT-THP exhibited higher tumor depression than THP-saline in vitro (74.35 ± 2.56 and 51.24 ± 1.45%) and in vivo (52.46 ± 2.41 and 96.85 ± 0.85%). The present findings indicate that SWNT delivery of THP for the treatment of bladder cancer leads to minimal side effects without loss of therapeutic efficacy. Therefore, this nanotechnology may play a crucial role in the improvement of intravesical treatment of bladder cancer.
- Open Access
- 23 February 2012
- Published by Academic Journals in African Journal of Microbiology Research
- Vol. 6 (7) , 1430-1436
PLCknockdown effectively decrease the MNU induced rat bladder tumorigenesis through a H-ras pathway
The crucial role of phospholipase C epsilon (PLC ε) in cancinogensis has been described recently. However, whether or not it decreases the methyl-nitroso-urea (MNU) induced rats’ bladder tumorigenesis and the probable mechanism remains poorly understood. Here, we investigated the efficacy of PLCε knockdown to MNU induced bladder tumor and its possible mechanism. First, a plasmid contains small hairpin Ribonucleic acid (RNA) against PLC ε was constructed. Then, this plasmid were intravesically installed into SD rats to silence the expression of PLC ε. 40 PLC ε silenced SD rats and 40 normal rats were intravesically installed with MNU, respectively. Another 10 normal SD rats were intravesically installed with saline. 12 weeks after installation, all rats were sacrificed. The bladders were harvested for pathological and histological examination, Reverse transcription polymerase chain reaction (RT-PCR) and Western-blotting. The pathological and histological examination results showed that 35 rats appeared tumor in normal rats group, while no rats appeared tumor in PLC ε silenced group and saline group. RT-PCR and Western-blotting showed PLC ε , PCNA were overexpressed in 35 tumor appeared rats and lowly expressed in other rats. The results reveal that the PLCε knockdown could interrupt the signal transduction in order to prevent MNU induced rats bladder tumorigenesis. Key words: PLCε, knockdown, MNU, Ras signal pathway and mechanism.
- 23 February 2012
- Published by Academic Journals in African Journal of Microbiology Research
- Vol. 6 (7) , 1430-1436
Open AccessPLCknockdown effectively decrease the MNU induced rat bladder tumorigenesis through a H-ras pathway
The crucial role of phospholipase C epsilon (PLC ε) in cancinogensis has been described recently. However, whether or not it decreases the methyl-nitroso-urea (MNU) induced rats’ bladder tumorigenesis and the probable mechanism remains poorly understood. Here, we investigated the efficacy of PLCε knockdown to MNU induced bladder tumor and its possible mechanism. First, a plasmid contains small hairpin Ribonucleic acid (RNA) against PLC ε was constructed. Then, this plasmid were intravesically installed into SD rats to silence the expression of PLC ε. 40 PLC ε silenced SD rats and 40 normal rats were intravesically installed with MNU, respectively. Another 10 normal SD rats were intravesically installed with saline. 12 weeks after installation, all rats were sacrificed. The bladders were harvested for pathological and histological examination, Reverse transcription polymerase chain reaction (RT-PCR) and Western-blotting. The pathological and histological examination results showed that 35 rats appeared tumor in normal rats group, while no rats appeared tumor in PLC ε silenced group and saline group. RT-PCR and Western-blotting showed PLC ε , PCNA were overexpressed in 35 tumor appeared rats and lowly expressed in other rats. The results reveal that the PLCε knockdown could interrupt the signal transduction in order to prevent MNU induced rats bladder tumorigenesis. Key words: PLCε, knockdown, MNU, Ras signal pathway and mechanism.
- 1 August 2011
- Vol. 33 (8) , 564-9
[Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces anti-tumor immune response].
To prepare IL-2-anchored and tumor-derived exosomes vaccine, and investigate the antitumor efficiency of the special cytotoxic T-lymphocytes induced by Ex/GPI-IL-2. To construct pEGFP-N1-IL2gpi plasmid coding a fusion gene of a DNA oligo encoding GPI-anchor signal sequence attaching to human IL-2 cDNA. Then T24 cell lines stably expressing GPI-IL-2 proteins (T24/GPI-IL-2) were established. Ex/GPI-IL-2 were isolated and purified by ultrafiltration and sucrose gradient centrifugation, and the morphology and molecule markers were analyzed. The mixed lymphocyte reaction study and cytotoxic study were performed to determine the proliferative effect of T lymphocytes and the cytotoxicity induced by Ex/GPI-IL-2. The pEGFP-N1-IL2gpi plasmid was successfully constructed, and cell lines stably expressing GPI-IL-2 fusion proteins were established. Ex/GPI-IL-2 were small vesicular and saucer-shaped in diameter of 30-90 nm, containing heat shock protein 70, intercellular adhesion molecule-1, MAGE-1 and GPI-IL-2. Ex/GPI-IL-2-pulsed could dendritic cells induce proliferation of T cells and cytotoxic immune response more efficiently (P<0.05). GPI-IL-2 gene-modified tumor cells can make the exosomes containing GPI-IL-2 with an increased anti-tumor effect. Our study provides a feasible approach for exosome-based tumor immunotherapy of bladder transitional cell tumors.
- 1 August 2011
- Vol. 33 (8) , 564-9
[Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces anti-tumor immune response].
To prepare IL-2-anchored and tumor-derived exosomes vaccine, and investigate the antitumor efficiency of the special cytotoxic T-lymphocytes induced by Ex/GPI-IL-2. To construct pEGFP-N1-IL2gpi plasmid coding a fusion gene of a DNA oligo encoding GPI-anchor signal sequence attaching to human IL-2 cDNA. Then T24 cell lines stably expressing GPI-IL-2 proteins (T24/GPI-IL-2) were established. Ex/GPI-IL-2 were isolated and purified by ultrafiltration and sucrose gradient centrifugation, and the morphology and molecule markers were analyzed. The mixed lymphocyte reaction study and cytotoxic study were performed to determine the proliferative effect of T lymphocytes and the cytotoxicity induced by Ex/GPI-IL-2. The pEGFP-N1-IL2gpi plasmid was successfully constructed, and cell lines stably expressing GPI-IL-2 fusion proteins were established. Ex/GPI-IL-2 were small vesicular and saucer-shaped in diameter of 30-90 nm, containing heat shock protein 70, intercellular adhesion molecule-1, MAGE-1 and GPI-IL-2. Ex/GPI-IL-2-pulsed could dendritic cells induce proliferation of T cells and cytotoxic immune response more efficiently (P<0.05). GPI-IL-2 gene-modified tumor cells can make the exosomes containing GPI-IL-2 with an increased anti-tumor effect. Our study provides a feasible approach for exosome-based tumor immunotherapy of bladder transitional cell tumors.